Reversible complete heart block in a patient with coronavirus disease 2019.
Varun BhasinMaryKate CarrilloBobby GhoshDanyaal MoinTheodore J MaglioneJohn KassotisPublished in: Pacing and clinical electrophysiology : PACE (2021)
Patients infected with novel coronavirus (SARS-CoV-2) can present with a variety of arrhythmias. We report an unusual case of reversible complete heart block (CHB) in the setting of acute coronavirus disease 2019 (COVID-19). A 23-year-old male with a history of Hodgkin's Lymphoma presented with dizziness and syncope. He was found to be in CHB associated with hypotension requiring a transvenous pacemaker. Methylprednisolone and remdesivir were started with rapid resolution of the CHB. Further study is needed to determine the mechanism of CHB in COVID-19. This case underscores the importance of including COVID-19 in one's differential diagnosis for acute CHB.
Keyphrases
- coronavirus disease
- sars cov
- respiratory syndrome coronavirus
- liver failure
- end stage renal disease
- respiratory failure
- heart failure
- chronic kidney disease
- ejection fraction
- drug induced
- newly diagnosed
- pulmonary embolism
- aortic dissection
- atrial fibrillation
- case report
- single molecule
- high dose
- low dose
- quantum dots
- sensitive detection